维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="THOMAS HD"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	A clinical and pharmacokinetie study of the combination of carbop latin and paclitaxel for epithelial ovarian caner显示文摘	Siddiqui N Boddy AV Thomas HD		0，，02：	1
2	Problem based learning of research skill显示文摘	Thomas HD Galen SW Gillherl G el al	2006	Journal of E 1 ectrocardiology2006，39，1：	1
3	6-thiogua- nine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance 显示文摘	Issaeva N Thomas HD Djureinovic T	2010	Cancer Res2010，70，15：	1
4	Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441显示文摘	Zhao Y Thomas HD Batey MA		0，，：	1
5	Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase显示文摘	Bryant HE Schultz N Thomas HD		0，，：	1
6	Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose)polymerase显示文摘	Bryant HE Schultz N Thomas HD		0，，7035：	1
7	Problem based learning of research skill 显示文摘	Thomas HD Galen SW Gillbert G	2006	Journal of Electrocardiology2006，39，1：	1
8	Specific killing of BRCA2-deficient turnouts with inhibitors of poly (ADP-ribose) polymerase 显示文摘	Bryant HE Schultz N Thomas HD	2005	Nature2005，434，7035：	1
9	Problem-based learning of research skills 显示文摘	Thomas HD Galen SW Gilbert G	2006	J of Electrocardiol2006，39，1：	1
10	A clinical and pharmacokinctic study of the combination of carboplatin and paclitaxel for epithelial ovarian caner 显示文摘	Siddiqui N Boddy AV Thomas HD	1997	British Journal of Cancer1997，75，2：	1
11	A clinical and pharmacokinetie Study of the combination of carboplatin and paclitaxel for epithelial ovarian caner显示文摘	Siddiqui N Boddy AV Thomas HD	1997	Br Cancer1997，75，2：	1
12	Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase显示文摘	Bryant HE Schultz N Thomas HD	2005	Nature2005，434，7035：	1
13	Specific killing ofBRCA2-deficient tumours with inhibitors of poly(ADP-ribose)polymerase显示文摘	Bryant HE Schultz N Thomas HD	2005	Nature2005，434，7035：	1
14	Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloprolif-erative disease显示文摘	Thomas EK Cancelas JA Chae HD	2007	Cancer Cell2007，12，5：	1
15	Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase显示文摘	Bryant HE Schultz N Thomas HD		0，，7035：	1
16	Demonstration of biological activity of CD40 ligand(CD 154)in the domestic cat显示文摘	Abigail LB Thomas HD Oswald J	2002	Cytokine2002，17，3：	1
17	Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase显示文摘	Bryant HE Schultz N Thomas HD	2005	Nature2005，434，7035：	1
18	A clinical and pharmacokinetie study of the combination of carboplatin and paclitaxel for epithelial ovarian caner显示文摘	Siddiqui N Boddy AV Thomas HD	1997	Br J Cancer1997，75，2：	1
19	A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer显示文摘	Siddiqui N Boddy AV Thomas HD	1997	Br J Cancer1997，75，2：	1
20	Specific killing of BRCA2- deficient tumours with inhibitors of poly(ADP-ribose) polymerase显示文摘	Bryant HE Schultz N Thomas HD	2005	Nature2005，434，7035：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示